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Histone ubiquitylation is a prominent response to
DNA double-strand breaks (DSBs), but how these
modifications are confined to DNA lesions is not
understood. Here, we show that TRIP12 and UBR5,
two HECT domain ubiquitin E3 ligases, control accu-
mulation of RNF168, a rate-limiting component of a
pathway that ubiquitylates histones after DNA
breakage. We find that RNF168 can be saturated by
increasing amounts of DSBs. Depletion of TRIP12
and UBR5 allows accumulation of RNF168 to supra-
physiological levels, followed by massive spreading
of ubiquitin conjugates and hyperaccumulation of
ubiquitin-regulated genome caretakers such as
53BP1 and BRCA1. Thus, regulatory and proteolytic
ubiquitylations are wired in a self-limiting circuit that
promotes histone ubiquitylation near the DNA
lesions but at the same time counteracts its exces-
sive spreading to undamaged chromosomes. We
provide evidence that this mechanism is vital for
the homeostasis of ubiquitin-controlled events after
DNA breakage and can be subverted during tumori-
genesis.
INTRODUCTION
Histone ubiquitylation is an integral part of intertwined pathways
that build up the DNAdamage epigenome (Lukas et al., 2011b). It
is triggered by RNF8, a RING finger E3 ligase that initiates ubiq-
uitylation of H2A and H2AX. These priming ubiquitin reactions
are edited by p97 segregase (Acs et al., 2011; Meerang et al.,
2011) and are amplified by RNF168, another RING finger E3ligase. The resulting lysine-63-linked ubiquitin polymers gen-
erate an interaction platform for chromatin-associated repair
and signaling factors, including 53BP1 and the RAP80/BRCA1
complex (Bothmer et al., 2010, 2011; Bouwman et al., 2010;
Bunting et al., 2010; Coleman and Greenberg, 2011; Hu et al.,
2011). In addition, RNF8/RNF168-mediated ubiquitylation of
H2A inhibits messenger RNA (mRNA) elongation, a mechanism
that has likely evolved to avoid collisions between transcription
and repair intermediates (Shanbhag et al., 2010). Chromatin
ubiquitylation also facilitates fusion of uncapped telomeres
(Peuscher and Jacobs, 2011), which can be viewed as a cellular
strategy to survive telomere attrition. Moreover, chromatin ubiq-
uitylation is required for formation of the G1 nuclear bodies that
shield DNA lesions generated during mitosis on genomic loci
exposed to replication stress (Harrigan et al., 2011; Lukas
et al., 2011a).
Apart from these positive impacts on genome stability, the
biochemical properties of RNF168 pose a potential threat; by
combining a catalytic RING domain and several ubiquitin-
binding domains within its structure (Doil et al., 2009; Pinato
et al., 2011; Stewart et al., 2009), RNF168 can amplify ubiquitin
conjugates generated by its own activity. Hence, once recruited
to the sites of DNA damage, RNF168 is poised to progressively
spread away from the DNA double-strand break (DSB) to
undamaged chromatin. An uncontrolled amplification of chro-
matin ubiquitylation could have deleterious consequences,
including unscheduled transcriptional silencing, or sequestering
cellular pools of limiting genome caretakers. Thus, an out-
standing conundrum is how cells control that these profound
epigenetic alterations remain confined to the sites of DNA
damage.
To control DNA-damage-induced chromatin ubiquitylations,
cells mobilize at least three deubiquitylating enzymes (DUBs),
BRCC36, USP3, and OTUB1, respectively (Doil et al., 2009;
Nakada et al., 2010; Nicassio et al., 2007; Shao et al., 2009).Cell 150, 697–709, August 17, 2012 ª2012 Elsevier Inc. 697
Figure 1. Identification of TRIP12 and UBR5
as Regulators of Chromatin Ubiquitylation
at Spontaneous DNA Lesions
(A) A schematic depiction of the screening
procedure combining siRNA arrays spanning the
human ubiquitinome and a readout based on
monitoring the increase of the GFP-RNF168-
associated fluorescence at the G1 nuclear bodies.
(B) A scatterplot of Z-scores derived from the
screen shown in (A). Insets show representative
images from manual re-examination of nuclear
body expansion in U-2-OS/GFP-RNF168 cells
treated with the indicated siRNAs; henceforth,
siRNA is abbreviated as si, Control as Con, and
TRIP12 and UBR5 as T12 and U5, respectively.
(C) List of genes whose knockdown by two inde-
pendent siRNA increased the expansion of GFP-
53BP1-decorated nuclear bodies.
Scale bars, 10 mm. See also Table S1.Although all these DUBs can counteract the activity of RNF168/
UBC13 holoenzyme, it is not clear whether they can fully control
the pathway once the amplification step catalyzed by RNF168 is
set in motion. For instance, it remains to be determined whether
these or other DUBs generate a constant ‘‘threshold’’ that needs
to be overcome by RNF168 or whether their activities are turned
on only to terminate chromatin ubiquitylation upon completion of
DNA repair.
To gain insight into the spatial regulation of stress-induced
chromatin ubiquitylations, we screened the human ubiquitinome
for suppressors of RNF168 and identified TRIP12 and UBR5, two
HECT domain E3 ligases implicated previously in a broad range
of physiological processes, including N-end rule proteolysis and698 Cell 150, 697–709, August 17, 2012 ª2012 Elsevier Inc.ubiquitin fusion degradation (Varshavsky,
2011), elimination of proteins uncoupled
from their physiological interactors
(Chen et al., 2010; Keppler and Archer,
2010; Park et al., 2008), cell-cycle check-
points (Henderson et al., 2006; Munoz
et al., 2007), and cotranslational protein
quality control (Pegoraro et al., 2012).
Our results reveal an unexpected function
of TRIP12 and UBR5 in delineating the
dynamic range for RNF168 accumulation
and thereby rendering the DNA-damage-
induced histone ubiquitylation intrinsi-
cally self limiting. We show that this
mechanism is used by cells to coordinate
repair dynamics and to avoid excessive
transcriptional silencing.
RESULTS
Identification of TRIP12 and UBR5
as Regulators of RNF168
To identify factors that limit the DNA-
damage-induced histone ubiquitylation,
we cultured U-2-OS cells stably express-ing green fluorescent protein (GFP)-RNF168 on small interfering
RNA (siRNA) arrays targeting the known human ubiquitinome
(Moudry et al., 2012), and we screened for genes whose knock-
down by at least two independent siRNAs increased GFP-
RNF168 accumulation on the G1 nuclear bodies formed around
spontaneous DNA lesions (Figure 1A). Prominent among the
positive hits were the structural and catalytic subunits of the
26S proteasome (Figures 1B and 1C and Table S1 available
online), indicating that unscheduled protein accumulation en-
hances histone ubiquitylation. Interestingly, out of all E3 ligases
included in the siRNA arrays, only TRIP12 and UBR5 recapitu-
lated this phenotype (Figures 1B and 1C), and their simultaneous
knockdown showed an additive effect in expanding the nuclear
Figure 2. Expansion of the Ubiquitylated
Nuclear Domains in TRIP12- and UBR5-
Depleted Cells Is Accompanied by Reduced
Transcription
(A) U-2-OS cells were transfected with the indi-
cated siRNAs for 72 hr and immunostained with
the FK2 antibody against conjugated ubiquitin.
Numbers indicate the fraction of nuclei with
enlarged ubiquitin-decorated nuclear bodies
(larger than 80 pixels). For each condition, a
randomly selected cohort of at least 500 cells was
analyzed. One pixel, 0.2 3 0.2 mm.
(B) U-2-OS cells were transfected with the indi-
cated siRNAs for 72 hr and immunostained with
antibodies to 53BP1 and ubiquitylated H2A.
(C) U-2-OS cells were transfected with siRNAs as
in (B) and immunostained with antibodies to
53BP1 and RNF168.
(D) U-2-OS cells were transfected with the indi-
cated siRNAs for 72 hr, incubated in the presence
of 5-ethinyl uridin (5-EU) for the last 1 hr, and
immunostained with antibodies to 53BP1. The
5-EU incorporation to nascent mRNA was devel-
oped with Click-iT chemistry. The fluorescence
intensity profiles were quantified along a line
drawn through the center of the nuclear bodies.
Insets show larger magnification of nuclear
bodies; graphs integrate data from ten cells for
each condition. Error bars represent SD.
Scale bars, 10 mm. See also Figure S1.territory occupiedbyGFP-RNF168 (Figure 1B). Thus, TRIP12and
UBR5 emerge as suppressors of RNF168.
TRIP12 and UBR5 Determine the Spreading
of Chromatin Ubiquitylation and Transcriptional
Silencing after DNA Damage
Fluorescence quantifications performed in naive U-2-OS cells
confirmed and extended the screening data by showing that
the knockdown of TRIP12 and UBR5 had an additive effect
on inducing large G1 nuclear bodies enriched in ubiquitin
conjugates (Figure 2A), including ubiquitylated H2A and H2AX,
the known targets of RNF168 (Figures 2B and S1A). These
expanded nuclear compartments accumulated endogenous
RNF168 itself (Figure 2C), as well as the established chromatin-
associated ubiquitin sensors RAP80, BRCA1, and 53BP1Cell 150, 697–709(Figures 2C, S1B, and S1C), but not
RNF8 (Figure S1D). The expansion
phenotypes were reproduced by multiple
siRNAs (Figures S2A and S2B) and are
seen also in primary human fibroblasts
(Figure S3A).
We excluded that the observed pheno-
types were caused by unspecific protein
aggregation. As we show in Figure S3B,
the expanded G1 nuclear bodies re-
mained highly dynamic and preserved
cell-cycle periodicity as their normal-
sized counterparts (Lukas et al., 2011a).
In addition, disruption of the upstreamregulators of chromatin ubiquitylation (inhibition of ataxia telangi-
ectasia mutated [ATM] and knockdown of MDC1 or RNF8,
respectively) abolished 53BP1 focus formation after combined
depletion of TRIP12 and UBR5 (Figures S3C and S3D), suggest-
ing that the signaling generated at the DSB sites is continuously
required to support RNF168 recruitment and the ensuing
spreading.
To explore whether the enlargement of the ubiquitin-enriched
chromatin domains entails functional consequences, we ex-
ploited the recent findings that the DSB-induced chromatin ubiq-
uitylations inhibit mRNA elongation (see Introduction). Indeed, by
combining immunostaining of 53BP1 with in situ detection of
nascent mRNA, we observed a marked reduction of de novo
mRNA synthesis throughout the expanded chromatin domains
(Figure 2D). Together, these data indicate that depletion of, August 17, 2012 ª2012 Elsevier Inc. 699
Figure 3. Catalytic Activities of TRIP12 and UBR5 Regulate Ubiquitin Spreading, but Not Chromatin Decondensation, after DNA Damage
(A) U-2-OS-TetO cells harboring 240 TetO repeats next to the I-SceI restriction site were transfected with the indicated siRNAs, induced to cut the I-SceI site, and
immunostained with antibodies to 53BP1; the locus with integrated TetO repeats was visualized by transient transfection of TetR-GFP.
(B) U-2-OS cells were transfected with the indicated siRNAs for 72 hr and immunostained with the indicated antibodies.
(C) Total fluorescence intensities of 53BP1 nuclear bodies were plotted against 53BP1 nuclear body areas. Coefficient of determination of a linear regression (R2)
and the slope of the linear regression are provided for each condition. The fraction of 53BP1 nuclear bodies with an area greater than 100 pixels is indicated. For
each condition, a randomly selected cohort of at least 300 cells was analyzed. One pixel, 0.2 3 0.2 mm.
(D) U-2-OS cells were transfectedwith the indicated siRNAs for 72 hr, exposed to IR (0.25Gy), and 45min later, were immunostainedwith an antibody to 53BP1. A
randomly selected cohort of 500 cells was analyzed; numbers indicate total fluorescence intensity per 53BP1 focus.
700 Cell 150, 697–709, August 17, 2012 ª2012 Elsevier Inc.
TRIP12 and UBR5 allows unusually vast expansion of RNF168-
catalyzed events accompanied by pronounced transcriptional
silencing.
Importantly, the RNF8/RNF168 pathway functionally interacts
with ATP-dependent chromatin remodelers (Lukas et al., 2011b),
and thus, one way the expansion of the nuclear bodies can occur
is via chromatin decompaction. However, at least three pieces of
evidence suggested that the phenotypes observed in TRIP12/
UBR5-depleted cells reflect an excessive spreading of ubiquitin
conjugates. First, the combined TRIP12/UBR5 depletion trig-
gered 53BP1 accumulation beyond the fluorescently labeled
genomic loci cleaved by an I-SceI endonuclease (Figure 3A).
Second, unlike the ubiquitin-dependent chromatin alterations,
g-H2AX did not expand beyond its normal range (Figure 3B).
Third, the 53BP1-associated fluorescence intensity increased
proportionally with the expanding nuclear body areas, again
supporting the spreading scenario rather than diluting the
density of ubiquitylated histones due to chromatin decondensa-
tion (Figure 3C). Collectively, these data suggest that depletion
of TRIP12 and UBR5 uncouples histone phosphorylation and
ubiquitylation by allowing the latter to spread beyond its physio-
logical boundaries.
Mechanisms of TRIP12- and UBR5-Mediated
Suppression of Chromatin Ubiquitylation
Because the G1 nuclear bodies can be viewed as compartments
with specialized functions (Harrigan et al., 2011; Lukas et al.,
2011a), we tested the impact of TRIP12/UBR5 knockdown
also on bona fide clastogen-induced DSBs. Indeed, after
exposing TRIP12/UBR5-depleted cells to low doses of ionizing
radiation (IR), we observed a marked enhancement (size and
intensity) of 53BP1 foci (Figures 3D and S3A). Conversely, over-
expression of TRIP12 or UBR5 degraded endogenous RNF168
(Figure 3E), which was accompanied by suppression of IR-
induced 53BP1 focus formation in a catalytic-dependent fashion
(Figure 3F). Thus, active TRIP12 and UBR5 E3 ligases are
required to suppress excessive chromatin ubiquitylations at IR-
induced DSBs.
To dissect how TRIP12 and UBR5 cooperate to regulate the
DNA-damage-induced ubiquitylation pathway, we analyzed the
abundance of its catalytic components. As shown in Figure 4A,
knockdown of UBR5 moderately increased the levels of all
three E3 ligases involved in this pathway—RNF8, RNF168, and
BRCA1, respectively. This is consistent with the recent identifi-
cation of UBR5 as a general component of cotranslational
protein quality surveillance (Pegoraro et al., 2012) and indicates
that the key catalytic components of genotoxic stress-induced
chromatin ubiquitylation are subjected to such regulation.
In contrast to UBR5, knockdown of TRIP12 triggered a
massive accumulation specifically of RNF168, a phenotype re-
produced by independent siRNAs (Figure S2B) and observed(E) U-2-OS cells were transfected with the expression plasmids for GFP-TRIP12
RNF168. Arrows mark the transfected cells.
(F) U-2-OS cells were transfected with the indicated expression plasmids; asteri
24 hr, cells were irradiated (1 Gy) and were immunostained 1 hr later as indicate
53BP1 and g-H2AX foci, respectively. The graph is a summary from three indep
Scale bars, 10 mm; error bars represent SD. See also Figures S3 and S4.regardless of exogenous DNA damage (Figure 4A). Consistently,
TRIP12 overexpression induced polyubiquitylation of RNF168
in cells (Figure S4A). The latter assay was performed with a
catalytically inactive RNF168 excluding an indirect role of
RNF168 autoubiquitylation. As mentioned in the Introduction,
TRIP12 often targets proteins that are uncoupled from stoi-
chiometric interactors, and we obtained evidence that such
a mechanism may also apply for RNF168. Specifically, we
have reported that silencing of HERC2, an established
RNF168-binding protein, markedly destabilized RNF168 (Bek-
ker-Jensen et al., 2010). As we show here, downregulation of
RNF168 induced by HERC2 depletion could be mitigated
by depletion of TRIP12 (Figure 4B). Importantly, a protein
degradation assay based on measuring the decay of photoacti-
vated GFP-RNF168 directly in living cells also revealed the
cooperative effect of TRIP12 and UBR5 in regulating RNF168
turnover and confirmed the dominant role of TRIP12 in the
process (Figure 4C).
In all of these assays, the cellular pool of free ubiquitin was not
limiting (Figures S4B–S4D). Furthermore, although depletion
of USP3 or RNF169, two established regulators of RNF168-
controlled events (Doil et al., 2009; Poulsen et al., 2012), in-
creased 53BP1 foci intensity, this effect was consistently less
pronounced compared to depletion of TRIP12 and UBR5 (Fig-
ure S4E), pointing to a dominant role of TRIP12 and UBR5 in sup-
pressing excessive RNF168-mediated chromatin ubiquitylation.
Thus, whereas both TRIP12 and UBR5 can be copurified with
ectopically expressed RNF168 to a similar extent (Figure S5A),
the regulation of chromatin ubiquitylation by these E3 ligases
appears to entail two complementary mechanisms. Whereas
UBR5 seems to control accumulation of all major pathway
components, TRIP12 likely represents a major specificity factor
that guards against excessive RNF168 in cell nuclei. Finally, all
of the above-described regulations operate strictly at the level
of protein stability because neither single nor combined knock-
down of TRIP12 and UBR5 affected RNF168 mRNA levels
(Figure S5B).
Stabilization and Enhanced Chromatin Loading
of RNF168 Are the Main Mediators of Ubiquitin
Spreading at Damaged Chromatin
After TRIP12 and UBR5 depletion, the hyperaccumulation
of RNF168 was followed by its increased loading on chromatin
(Figure 4D). In contrast, we could not detect enhanced chro-
matin loading of RNF8 (Figure S5C), suggesting that the ex-
pansion of the ubiquitylated chromatin relies on RNF168. In
support of this conclusion, overexpression of RNF168, but
not RNF8 or BRCA1, was sufficient to expand chromatin
domains around spontaneous DNA lesions marked by 53BP1
(Figure 4E; C.L. and J.L., our unpublished data). In addition,
RNF8 did not expand beyond its normal chromatin territory inor GFP-UBR5, incubated for 24 hr, and immunostained with an antibody to
sks indicate an inactivating point mutation in the catalytic HECT domain. After
d, and the GFP-positive nuclei in each condition were scored for numbers of
endent experiments.
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Figure 4. TRP12 and UBR5 Determine the
Abundance and Chromatin Loading of
RNF168
(A) U-2-OS cells were transfected with siRNA for
72 hr and irradiated as indicated. Whole-cell
extracts (WCE) were analyzed by immunoblotting.
(B) U-2-OS cells conditionally expressing Dox-
ycyclin (Dox)-inducible HERC2 shRNA were
induced by incubating in the media with Dox for
120 hr. For the last 72 hr, cells were transfected
with the indicated siRNAs. WCE were analyzed by
immunoblotting with the indicated antibodies.
(C) U-2-OS cells stably expressing photo-
activatable GFP-RNF168 were treated with the
indicated siRNAs for 72 hr and photoactivated,
and the GFP-associated fluorescence intensities
were recorded at the indicated time points. The
data represent background-subtracted fluores-
cence intensities averaged from ten cells for each
condition. Error bars represent SD.
(D) U-2-OS cells were transfected with siRNAs for
72 hr and irradiated as indicated. Chromatin-en-
riched fractions were analyzed by immunoblotting.
(E) U-2-OS cells were transfected with expression
plasmids for HA-RNF168 and HA-RNF8, respec-
tively. After 24 hr, the cells were immunostained
with an antibody to the hemagglutinin (HA) tag.
Arrows mark the nuclear bodies occupied by
the respective proteins. Nuclear DNA was stained
by DAPI.
Scale bar, 10 mm. See also Figures S4 and S5.TRIP12- and UBR5-depleted cells (Figure S1D), and its knock-
down did not prevent RNF168 stabilization (Figure S5D), sug-
gesting that the regulation of the RNF168 protein abundance
by TRIP12 and UBR5 is autonomous. However, depletion of
RNF8 did impair DNA-damage-induced chromatin loading of
RNF168 in TRIP12- and UBR5-depleted cells (Figures S3D
and S5D). Together, these results suggest that, in the absence
of TRIP12 and UBR5, the DSB-induced ubiquitylation path-
way operates under the same principles as in normal cells
with the exception that it is hyperactive; this includes unsched-
uled RNF168 accumulation, its excessive loading on chromatin,
and spreading of ubiquitin conjugates far away from the DNA
lesions.702 Cell 150, 697–709, August 17, 2012 ª2012 Elsevier Inc.The Levels of RNF168 Render the
Ubiquitin Signaling Rate Limiting
When combined, the previous results
suggest that, due to its unique propen-
sity to autoamplify (see Introduction),
RNF168 might have evolved as the prime
target for mechanisms that control the
magnitude of DNA-damage-induced
chromatin ubiquitylation. If true, it should
be possible to generate conditions when
the pool of endogenous RNF168 be-
comes limiting. To test this, we used the
TRIP12 and UBR5 knockdown as a
molecular tool to maximally mobilize
endogenous RNF168, exposed cells toincreasing doses of IR (0.25–4 Gy), and quantified in hundreds
of randomly chosen cells the magnitude of ubiquitin-dependent
protein accumulations at damaged chromatin. As a readout, we
again used 53BP1 because of the strict dependency of its
chromatin accumulation on RNF168 (Doil et al., 2009; Stewart
et al., 2009) and the fact that it is a fairly abundant protein whose
levels were not changed by TRIP12 or UBR5 manipulations
(Figure S5E).
Strikingly, naive U-2-OS cells and primary human fibroblasts
responded to the increasing dose of IR by a progressive reduc-
tion of fluorescence intensity and areas of nuclear foci occupied
by 53BP1 (Figures 5A, S6A, and S6B). Although the sum of
53BP1 fluorescence associated with all IR-induced foci per
Figure 5. RNF168 Abundance Is Rate
Limiting for 53BP1 Focus Formation
(A) U-2-OS cells were transfected with siRNAs for
72 hr and exposed to increasing doses of IR as
indicated, and after 1 hr, theywere immunostained
with an antibody to 53BP1. Wide-field images
were acquired from randomly selected fields. The
graph shows the total fluorescence intensity per
53BP1-decorated nuclear focus. Representative
images for each condition are shown. Scale bar,
10 mm.
(B) U-2-OS cells were transfected with siRNAs
for 72 hr and irradiated as indicated, and 1 hr later,
they were immunostained with an antibody to
53BP1. Wide-field images of 53BP1 were ac-
quired from randomly selected fields. The graph
shows the average sum of total fluorescence
intensity associated with 53BP1 nuclear foci
normalized to the total fluorescence intensity of
53BP1 per nucleus.
(C) U-2-OS were transfected with control siRNA
and irradiated as indicated, and 1 hr later, they
were immunostained with antibodies to 53BP1
and g-H2AX. Wide-field images were acquired
from randomly selected fields and analyzed for the
number of nuclear foci per nucleus. Representa-
tive images are shown.
(D) U-2-OS cells were transfected with the TRIP12
and UBR5 siRNAs and analyzed as in (C).
(E) U-2-OS cells expressing GFP-RNF168 or naive
U-2-OS cells were irradiated and analyzed for
53BP1-associated fluorescence as in (A).
(F) U-2-OS cells stably expressing GFP-RNF168,
U-2-OS cell line induced to express RNF168
shRNA for 72 hr (used here as a negative control
for suppression of 53BP1 focus formation), or
naive U-2-OS cells were irradiated and analyzed
for 53BP1 foci number. For each condition in
(A)–(F), a randomly selected cohort of at least 500
cells was analyzed.
Scale bars, 10 mm. See also Figure S6.nucleus increased up to 1–2 Gy (corresponding to 20–40 DSB), it
began to decline at higher doses (Figure 5B). Together, these
data suggest that, after exceeding a dynamic range defined by
RNF168 abundance, the increasing amount of DNA breaks fails
to induce productive chromatin ubiquitylation. Consistent with
this conclusion, the absolute number of 53BP1 foci per nucleus
increased only up to 1 Gy of IR (Figure 5C). Importantly, the
number of g-H2AX foci continued to rise throughout the entire
dose range (Figure 5C), suggesting that the DNA-damage-
induced ubiquitylation is an autonomous and rate-limiting
pathway that, unlike histone phosphorylation, can be saturated
by relatively low amounts of DSB.
Most importantly, the combined TRIP12/UBR5 knockdown
elevated the threshold to higher IR doses at all assay levels,
including the intensity, area, and number of 53BP1-decoratedCell 150, 697–709nuclear foci, respectively (Figures 5A,
5B, 5D, and S6B). To test whether this
can be attributed to TRIP12/UBR5-medi-
ated control of RNF168 abundance, werepeated these measurements in cells stably expressing ectopic
GFP-RNF168 (Figure S6C). Under these conditions, we also
observed enhancement of 53BP1-decorated chromatin areas
(Figures 5E and S6D) and productive 53BP1 focus formation at
higher doses (Figure 5F). We conclude that the cellular capacity
to ubiquitylate chromatin after DNA breakage is limited and that
the levels of RNF168 set a threshold, which determines the
extent of this modification.
The RNF168 Threshold Determines the Dynamics
of DSB Repair
To test the consequences of the threshold imposed by the
TRIP12/UBR5-RNF168 crosstalk for DNA repair, we turned to
one of the key functions of RNF168, namely its ability to recruit
to the DSB-flanking chromatin various genome caretakers,, August 17, 2012 ª2012 Elsevier Inc. 703
Figure 6. Deregulation of TRIP12 and UBR5
Alters the Dynamics of DNA Repair
(A) U-2-OS cells were transfected with the indi-
cated siRNA for 72 hr and irradiated. WCE were
analyzed by immunoblotting.
(B) U-2-OS cells were irradiated (2 Gy), and 1 hr
later, they were immunostainedwith an antibody to
RPA (the FITC channel); nuclear DNA was coun-
terstained by DAPI. Cell-cycle distribution was
determined for each individual cell by quantifying
the total DAPI and chromatin-bound RPA intensity
per nucleus.
(C) U-2-OS cells were transfected with the indi-
cated siRNAs, irradiated, immunostained with
antibodies to RPA and RAD51, sorted according to
cell cycle as in (B), and subjected to an automated
analysis of RAD51 focus formation. At least 500
cells were analyzed for each condition; represen-
tative images are shown.
(D) U-2-OS cells were transfected with siRNAs for
72 hr and irradiated. Where indicated, cells were
treated for 2 hr with ATMor DNA-PK inhibitors prior
to irradiation. WCE were analyzed by immuno-
blotting (left). In parallel, cells were treated with the
indicated siRNAs and inhibitors as indicated, irra-
diated (2 Gy), and after 4 hr, were subjected to an
automated single cell analysis for the number of
MDC1 nuclear foci (right).
(E) U-2-OS cells were treated with the indicated
siRNAs and inhibitors, irradiated, and analyzed
as in (D).
Scale bar, 10 mm. See also Figure S7.including proteins that influence DNA end processing (see Intro-
duction). Indeed, we observed that depletion of TRIP12 and
UBR5 cooperated in reducing phosphorylation of replication
protein A (RPA), a surrogate of DSB resection (Figure 6A). This
was, at least in part, mediated by elevated RNF168 because its
simultaneous knockdown restored RPA phosphorylation (Fig-
ureS7A).Consistently, whenweextended these assaysobtained
at a single time point bymonitoring temporal dynamics of RAD51
focus formation, weobserved a lower incidence and amore rapid
clearance of RAD51 foci after TRIP12 and UBR5 depletion
(Figures 6B and 6C). Thus, excessive chromatin ubiquitylation
appears to trigger faster and/or more efficient DSB repair.
Several independent experiments supported this conclusion.
Although TRIP12/UBR5 depletion did not generally affect IR-704 Cell 150, 697–709, August 17, 2012 ª2012 Elsevier Inc.induced ATM autophosphorylation (Fig-
ure S7B), it caused a marked reduction
of KAP1 phosphorylation (Figure 6A),
and also, this effect appeared to be medi-
ated by elevated RNF168 (Figure S7A).
KAP1 is an ATM substrate whose phos-
phorylation correlates with slow DSB
repair kinetics (Goodarzi et al., 2010).
Consistently, we found that KAP1 phos-
phorylation increased when DSB repair
by nonhomologous end-joining (NHEJ)
was compromised (Figures 6D, 6E, and
S7C). Strikingly, depletion of TRIP12 andUBR5 partially suppressed even this elevated KAP1 phosphory-
lation (Figures 6D and 6E), suggesting that the hyperaccumula-
tion of RNF168 might rescue efficient DSB repair, even under
these suboptimal conditions.
We validated and further extended these biochemical anal-
yses by monitoring physiological parameters associated with
DNA repair. First, we observed that the depletion of TRIP12
and UBR5 accelerated the disappearance of g-H2AX and
MDC1 repair foci both in naive U-2-OS cells (Figures S7D and
S7E) and in cells with reduced activities of DNA-dependent
protein kinase catalytic subunit (DNA-PK) or poly(ADP-ribose)
polymerase (PARP) enzymes (Figures 6D and 6E). Second, by
using reporter assays, we detected a significant increase of
the NHEJ-directed repair (Figure 7A), which was consistent
Figure 7. Mechanisms Determining RNF168
Turnover Influence Survival after DNA
Damage and Can Be Deregulated in Human
Cancer
(A) H1299 dA3-1 cells were transfected with indi-
cated siRNAs for 24 hr, followed by transfection
with a plasmid expressing I-SceI for 72 hr, and
then they were harvested. Where indicated, DNA-
PKcs inhibitor NU7026 was added to cells at the
time of I-SceI transfection. The proportion of GFP-
positive cells (as a measure of NHEJ activity) was
determined by flow cytometry. Data represent the
mean from three experiments.
(B) U-2-OS/DR-GFP cells were transfected with
siRNAs as indicated and then cotransfected with
expression plasmids for I-SceI and RFP for 48 hr.
Flow cytometry analysis of GFP/RFP ratio was
used to measure HR efficiency. Data represent the
mean of five experiments.
(C) MCA survival assay. U-2-OS cells expressing
GFP were cotransfected with TRIP12 and UBR5
siRNAs for 48 hr andmixed in a 1:1 ratiowith aU-2-
OS cell line expressing mCherry transfected with
control siRNA. Where indicated, U-2-OS/YFP-
RNF168 induced to express the transgene by
addition of Doxycycline (Dox) were mixed with the
U-2-OS/mCherry cells and processed as above.
After an additional 24hr, cellswere irradiated (5Gy)
and were analyzed 72 hr later by flow cytometry.
The survival was determined as the GFP/mCherry
ratio. The data represent a summary from three
experiments. Error bars in (A)–(C) represent SD.
(D) Paraffin sections from the indicated tumor
types were immunostained with antibodies to
53BP1 or RNF168. Insets show larger magnifica-
tions of the marked fields; arrows point to nuclear
bodies. The HPV status of the depicted tumors is
indicated.
(E) Model of TRIP12/UBR5-mediated suppression
of chromatin ubiquitylation after DNA breakage.
Left, TRIP12 and UBR5 determine the nuclear
pool of RNF168. This pool is under full control by
the upstream regulators and is available to ubiq-
uitylate a limited fraction of the DSB-flanking
chromatin. Right, in the absence of TRIP12 and
UBR5, a fraction of hyperaccumulated RNF168
escapes upstream regulators and triggers
spreading of H2A and H2AX ubiquitylation far
away from the initial DNA lesions.
Scale bar, 10 mm.with the increased loading of RNF168 and 53BP1 on the
damaged loci under these conditions. Of note, homology-
directed repair was also elevated in TRIP12/UBR5-depleted
cells (Figure 7B), suggesting a broader impact of protein quality
control in DNA damage responses (see Discussion). Third,
a multicolor competition assay (MCA) (Smogorzewska et al.,
2007) revealed improved short-term survival after irradiation
both in TRIP12/UBR5-depleted cells and in cells engineered to
transiently increase the RNF168 pool from a conditional yellow
fluorescent protein (YFP)-RNF168 transgene (Figure 7C). Impor-
tantly, depletion of 53BP1, the sensor of chromatin ubiquityla-
tion, had an opposite effect and decreased cell survival under
these conditions (Figure 7C). Together, these data suggest thatboosting chromatin ubiquitylation enhances repair efficiency of
clastogen-induced DSBs.
Elevated RNF168 and Expanded 53BP1 Nuclear Bodies
Are Associated with Advanced HPV-Transformed
Human Malignancies
In search for disease-associated aberrations of the described
mechanisms, we noticed a recent study describing unusually
large 53BP1 foci in advanced human papillomavirus (HPV)-posi-
tive cervical cancers (Matsuda et al., 2011). We revisited this
issue and found that diverse HPV-positive tumor types contain
markedly enlarged 53BP1 nuclear bodies, and more signifi-
cantly, that this is accompanied by dramatically increased levelsCell 150, 697–709, August 17, 2012 ª2012 Elsevier Inc. 705
of endogenous RNF168 (Figure 7D). Specifically, 50% (n = 20) of
HPV-associated tumors showed expanded 53BP1 bodies and
high levels of RNF168, whereas none (n = 40) of HPV-negative
carcinomas showed these phenotypes. Among the HPV-associ-
ated tumors, the highest incidence of nuclear body expansion
was detected in carcinomas of anus (five of six), followed by
uterine cervix (four of eight) and rhinopharynx (one of six).
Thus, although a detailed assessment of RNF168 gain of func-
tion in pathogenesis of human cancer awaits more dedicated
studies, these results suggest that such a connection indeed
exists and that the pathway described here could be subverted
by transforming viruses such as the HPV.
DISCUSSION
Here, we uncovered a mechanism that provides three additions
to the current concepts of chromatin responses to DNA
breakage. First, we show that an excessive spreading of a
DNA-damage-associated chromatin modification can occur.
Second, we identified TRIP12 and UBR5 as two suppressors
of such spreading. Third, our results indicate that the rate-
limiting nature of chromatin ubiquitylation influences physiolog-
ical consequences of genotoxic stress, such as the extent of
transcriptional silencing, the dynamics of DSB repair pathways,
and cell survival.
Our results can be integrated into the following model (Fig-
ure 7E): under physiological conditions, TRIP12 andUBR5deter-
mine the size of the RNF168 nuclear pool, which dynamically
responds to the plethora of upstream regulators and supports
limited chromatin ubiquitylation confined to the vicinity of the
DNA lesions. In the absence of TRIP12 and UBR5, RNF168
accumulates to supraphysiological levels, escapes the fine-
tuning effect of upstream regulators, and triggers spreading of
histone ubiquitylations away from the DSB sites. The salient
feature of this model is that the excessive spreading of DNA-
damage-induced ubiquitylation is not limited by physical
‘‘insulators’’ within the higher-order chromatin structure but is
determined by the number of RNF168 molecules.
Mechanistically, the cooperative effect of TRIP12 and UBR5 in
keeping the RNF168 levels within the desirable limit could
resemble their yeast orthologs (UFD4 and UBR1, respectively)
that synergize in degrading shared substrates by enhancing
the processivity of ubiquitin chain formation (Hwang et al.,
2009, 2010). However, our data suggest that mammalian
TRIP12 and UBR5 cooperate in suppressing RNF168 at an addi-
tional level. Based on its strong and selective impact on the
RNF168 protein levels, TRIP12 appears to be the prime E3
ligase, which monitors nuclear RNF168 and thus guards against
excessive chromatin ubiquitylation. An interesting parallel
comes from studies of TRIP12 in different biological settings,
which showed that the ARF, BAF57, and APP-BP1 proteins are
targeted for TRIP12-mediated proteolysis only when uncoupled
from their physiological binding partners (Chen et al., 2010; Kep-
pler and Archer, 2010; Park et al., 2008). Intriguingly, there is
a precedent that RNF168 is destabilized in the absence of
HERC2, one of its interacting proteins (Bekker-Jensen et al.,
2010), and we show that this enhanced proteolysis can be sup-
pressed by depleting TRIP12. In this regard, it is possible that706 Cell 150, 697–709, August 17, 2012 ª2012 Elsevier Inc.TRIP12 may control RNF168 turnover also by targeting one of
its interacting partners and thereby ‘‘unshielding’’ it from the
proteolytic machinery.
The second, arguably more basic, level of regulation seems to
be provided by UBR5, which has recently emerged as an integral
component of the cotranslational protein surveillance machinery
(Pegoraro et al., 2012). Indeed, we show that knockdown of
UBR5 leads to a modest but reproducible increase of all E3
enzymes involved in the DNA damage ubiquitylation pathway
(RNF8, RNF168, and BRCA1). Consequently, attenuation of
such surveillance would inevitably prime cells to escape physio-
logical regulatory cues and become exquisitely sensitive to
events that enhance chromatin ubiquitylation. We envisage
that other members of the UBR family of E3 ligases or additional
factors involved in ubiquitin fusion degradation (Varshavsky,
2011) can also participate in preventing ‘‘unscheduled spikes’’
of histone ubiquitylations. If this were the case, it would be inter-
esting to investigate whether this operates directly via RNF168
as described here or whether there are additional rate-limiting
factors along the pathway. Our findings (e.g., Figure 5) that the
chromatin ubiquitylation can still be saturated to some extent,
even in cells with elevated RNF168, indicate that, especially after
massive DSB formation, additional factors can become limiting.
In our experimental conditions, the dynamic range of chro-
matin ubiquitylation is saturated at IR doses that correspond to
(maximally) 20–40 DSBs. Within that range, the TRIP12/UBR5-
mediated control over RNF168 abundance effectively supports
chromatin ubiquitylation of most DSBs. Because one conse-
quence of chromatin ubiquitylation is the increased chromatin
retention of 53BP1, a factor that promotes end joining and
restrains resection of DNA ends (Bothmer et al., 2011; Bouwman
et al., 2010; Bunting et al., 2010; Cao et al., 2009), the bulk of
DSBs under these conditions are likely repaired by NHEJ, which
is a conclusion that is supported by the enhanced NHEJ effi-
ciency measured in a cell-based reporter assay. By contrast,
once the extent of DNA damage overcomes the threshold,
DSBs progressively lose the ability to induce histone ubiquityla-
tion (and 53BP1 chromatin retention), which in turn may increase
the incidence of abortive NHEJ attempts and render the DSB
repair more dependent on homology-directed repair.
An interesting ramification of how chromatin ubiquitylation
contributes to repair efficiency is our observation that the deple-
tion of TRIP12 and UBR5 enhances both NHEJ and homologous
recombination (HR) (albeit the latter to a lower extent). The stim-
ulating effect on NHEJ is consistent with the recent results
demonstrating that some of the key ubiquitin sensors at the
DSB-modified chromatin, such as 53BP1, promote DNA end
joining (Bunting et al., 2012; Introduction). In case of HR, the
mechanism remains more elusive, but several scenarios come
to mind. Most notably in this regard, the observation that the
DSB-associated chromatin events shift both major repair mech-
anisms to the same direction is not unprecedented. A recent
study (Galanty et al., 2009) showed that the depletion of the
DSB-associated SUMO ligases (enzymes that operate directly
on the RNF168 pathway) attenuates both NHEJ and HR. Trans-
lated to our experimental system, we envisage that, in addition
to RNF168, TRIP12/UBR5-deficient cells accumulate other
genome caretakers that allow more efficient HR. Such proteins
could affect specific loci and/or might be restricted to a defined
stage of cell-cycle progression. For instance, because the
enhanced chromatin ubiquitylation in TRIP12/UBR5-depleted
cells entails hyperaccumulation of BRCA1, it is possible that,
close to the G2/M transition, when the progressive chromatin
condensation starts to displace NHEJ factors such as 53BP1,
the high local concentration of BRCA1 can facilitate HR of hith-
erto unresolved DSBs.
Aberrations of both TRIP12 and UBR5 have been reported in
several types of human malignancies (Clancy et al., 2003;
O’Brien et al., 2008; Yoo et al., 2011), and it is possible that
excessive chromatin ubiquitylation in such cases might con-
tribute to cancer progression. Although a systematic analysis
of how chromatin hyperubiquitylation contributes to cancer
development requires dedicated studies, our results identified
at least two areas that may serve as useful leads in this effort.
First, the increased survival in RNF168 overproducing cells could
provide selective advantage to cancer cells that intrinsically
proliferate under increased genotoxic stress (Bartkova et al.,
2005). Second, the high incidence of elevated RNF168 and
expanded 53BP1 chromatin domains in HPV-transformed
tumors indicates that, in addition to the downregulation of
RNF8 and RNF168 triggered by herpes-virus-encoded proteins
(Lilley et al., 2010), oncogenic viruses could have evolved an
alternative strategy and could subvert this pathway to expand
the life span of host cells. The HPV-encoded E6 oncoprotein is
a founder of the HECT domain E3 ligases, and it is intriguing to
speculate that one way it subverts the host cell metabolism is
via competing out cellular enzymes of the same family, including
TRIP12 and UBR5.
EXPERIMENTAL PROCEDURES
DNA, RNA, and Transfections
A plasmid containing the full-length complementary DNA (cDNA) for human
TRIP12 was obtained from Source BioScience (cloneIRCMp5012E0132D;
transcript ENST 00000389044, Ensembl release 66) and was subcloned into
the pAc-GFP-C1 vector (Clontech). The catalytically inactive version of
TRIP12 (*HECT; C2007A) was generated by using the QuickChange Site-
Directed Mutagenesis Kit (Stratagene). Full-length, untagged UBR5 cDNA
was subcloned into pDNR221 from pEGFP-C1_EDD (Henderson et al.,
2002). Catalytically inactive UBR5 *HECT (C2768A) was generated by replac-
ing a C-terminal fragment of the wild-type (WT) cDNA with a synthetic
sequence. Both WT and mutant UBR5 cDNA were cloned into pcDNA6.2/
N-EmGFP-DEST (V356-20, Invitrogen). Plasmids for RNF8 and RNF168
were described (Doil et al., 2009; Mailand et al., 2007). The TetR-GFP plasmid
was a gift from E. Soutoglou. Photoactivatable GFP plasmid was provided by
J. Lipincott-Schwartz. Plasmid transfections were performed with the Lipo-
fectamine LTX with Plus Reagent (Invitrogen). siRNA transfections were
performed with siRNA duplexes (25 nM) by using Lipofectamine RNAiMAX
(Invitrogen). For siRNA specificity, see Figure S2.
Cell Culture and Generation of DSBs
Human U-2-OS osteosarcoma cells, primary BJ fibroblasts and HEK293T
cells, were grown in Dulbecco’s modified Eagle’s medium (DMEM) containing
10% fetal bovine serum (GIBCO). U-2-OS cell lines expressing GFP-RNF168,
GFP-53BP1, a Doxycycline-inducible small hairpin RNA (shRNA) to RNF168,
and a Doxycycline-inducible shRNA to HERC2 were described (Doil et al.,
2009; Bekker-Jensen et al., 2010). U-2-OS cell lines with Doxycycline-
inducible YFP-RNF168 or constitutively expressed photoactivatable GFP-
RNF168, free GFP, and free mCherry, respectively, were generated by
standard protocols (Bekker-Jensen et al., 2005; Lukas et al., 2004). Similarprocedures were used to generate a U-2-OS cell line with stably integrated
I-SceI restriction site flanked by 240 TetO repeats (Lau et al., 2003). Primary
BJ fibroblasts were obtained from ATCC. X-ray irradiation was done with a
XYLON.SMART 160E/1.5 device (150kV, 6 mA; YXLON International A/S,
Taastrup, Denmark) delivering 11.8 mGy per second. Soft X-rays were largely
filtered out with a 3 mm aluminum filter. Chemical inhibitors of PARP (ABT888,
10 mM), ATM (Kudos 55933, 10 mM), and DNA-PK (NU7441, 2 mM) were used.
The multicolor competition assay was done as described (Smogorzewska
et al., 2007); the results in Figure 7Cwere reproduced after swapping the recip-
ient cell lines (GFP and mCherry, respectively) for the siRNA treatments. NHEJ
and HR reporter assays were described (Poulsen et al., 2012).
Microscopy and Image Analysis
Automated wide-field microscopy was performed on an Olympus ScanR
system (motorized IX81 microscope) with ScanR Image Acquisition Software
and 203/0.75 NA (UPLSAPO203) and 403/0.9 NA (UPLSAPO 403) dry objec-
tives, a quadruple-band filter set for Dapi, FITC, Cy3 andCy5 fluorescent dyes,
an MT20 Illumination system, and a digital monochrome Hamamatsu C9100
electron multiplying (EM)-charge-coupled device (CCD) camera. Confocal
microscopy was performed on an LSM-510 (Carl Zeiss Microimaging Inc.)
mounted on an upright Zeiss-Axioimager with an oil immersion objective
(Plan-Apochromat 403/1.3). Time-lapse microscopy was performed on Axi-
oOserver.Z1 wide-field microscope (Carl Zeiss Microimaging Inc.) with a
403 oil immersion objective (Plan-Apochromat), a CCD camera (Coolsnap
HQ, Roper Scientific), motorized stage, and fast shutters (Sutter Instruments).
See also Extended Experimental Procedures.
Statistical Analysis
Differences in repair and survival assays were analyzed by Student’s t test.
Data Online
Original images of the GFP-RNF168 screen (Figure 1B and Table S1) are
deposited in theMitocheck database (http://www.mitocheck.org/cgi-bin/mtc).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and one table and can be found with this article online at http://dx.doi.
org/10.1016/j.cell.2012.06.039.
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